Unaudited Financial Results for the 3rd Quarter and Nine Months ended 31.12.2025.
VIMTALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.2 pts less than Nifty Microcap 250 and 11.6 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vimta Labs Limited has submitted its unaudited financial results for the third quarter (October–December 2025) and the nine-month period ending 31 December 2025 to the stock exchange, as required under listing regulations. The headline confirms the filing of quarterly numbers but does not include specific revenue, profit, or margin figures in the available text. Investors should refer to the full results document for detailed performance metrics and segment-wise breakdown. The 'unaudited' tag indicates these numbers are subject to limited review by the statutory auditors and may see minor adjustments.
This is a routine quarterly compliance filing and is not, by itself, a positive or negative trigger for the stock. Shareholders should review the actual numbers in the attached PDF to assess revenue trends, profit growth, and margin direction versus prior periods.